CochLear (OTCMKTS:CHEOY) Share Price Crosses Above 200 Day Moving Average – Here’s Why

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY)’s share price passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $52.01 and traded as high as $54.00. CochLear shares last traded at $53.09, with a volume of 13,588 shares.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CHEOY shares. Jefferies Financial Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Canaccord Genuity Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 18th. Finally, Royal Bank Of Canada downgraded shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price on the stock. in a report on Thursday, July 16th. Five research analysts have rated the stock with a Hold rating. According to MarketBeat, CochLear presently has an average rating of “Hold” and an average target price of $117.00.

CochLear Stock Performance

The company has a fifty day simple moving average of $48.22 and a 200-day simple moving average of $52.01.

CochLear Company Profile

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products designed to help users hear in a range of environments.

The company also provides clinical support, rehabilitation resources, software, technical services and ongoing care for recipients, clinicians and hearing professionals.